O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF: Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer
Based on laboratory testing and published research: Dihexa dissolves well in DMSO at a concentration of 1mg/ml
The good news is that dermatologist-approved treatments can significantly reduce pain, speed healing, and prevent long-term damage when applied correctly
The peptides effects on growth factor pathways create similar theoretical concerns about promoting unwanted cell proliferation in susceptible individuals
Studies have examined ipamorelin in models of lean mass accretion, visceral fat reduction, and metabolic syndrome, with findings consistent with the broader GH/IGF-1 axis literature